Medicine
Olmesartan 40 mg tablet
Olmesartan 40 mg tablet is a generic prescription medicine for oral use, made by 28 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F).
Key facts
- Active ingredient (INN)
- Olmesartan
- Brand
- Sold under the generic name
- Strength
- 40 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 30 tablets, 90 tablets and 120 more
- Manufacturers
- Alembic PharmaceuticalsIndiaAurobindo PharmaIndiaJubilant Cadista PharmaceuticalsIndiaAscend LaboratoriesIndiaGlenmark PharmaceuticalsIndiaAccord HealthcareIndiaCadila PharmaceuticalsIndiaMacleods PharmaceuticalsIndiaCamber PharmaceuticalsIndiaLifestar PharmaIndia28 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C09CA08 Olmesartan
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 April 2016
- Identifiers
- RxCUI 349373, 349401, 349405DailyMed set ID 53b8d406-a4f3-46ee-9aec-d70f7d806876, 5f410909-a68a-4ada-963a-32018d37572f, 9d9f1c08-4f65-484c-943e-7e664281910f +37NDC 31722-854, 50090-6632, 50090-6633 +37Application ANDA205499, ANDA204814, ANDA203281 +12
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 28 labelers. The register lists 123 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet, film coated in 1 carton | 46708-133-10 | Alembic PharmaceuticalsIndia | 24 April 2017 |
| 30 tablet, film coated in 1 bottle | 46708-133-30 | Alembic PharmaceuticalsIndia | 24 April 2017 |
| 90 tablet, film coated in 1 bottle | 46708-133-90 | Alembic PharmaceuticalsIndia | 24 April 2017 |
| 1000 tablet, film coated in 1 bottle | 46708-133-91 | Alembic PharmaceuticalsIndia | 24 April 2017 |
| 100 tablet, film coated in 1 carton | 62332-133-10 | Alembic PharmaceuticalsIndia | 24 April 2017 |
| 30 tablet, film coated in 1 bottle | 62332-133-30 | Alembic PharmaceuticalsIndia | 24 April 2017 |
| 90 tablet, film coated in 1 bottle | 62332-133-90 | Alembic PharmaceuticalsIndia | 24 April 2017 |
| 1000 tablet, film coated in 1 bottle | 62332-133-91 | Alembic PharmaceuticalsIndia | 24 April 2017 |
| 30 tablet, film coated in 1 bottle, plastic | 16729-322-10 | Accord HealthcareIndia | 27 April 2017 |
| 90 tablet, film coated in 1 bottle, plastic | 16729-322-15 | Accord HealthcareIndia | 27 April 2017 |
| 1000 tablet, film coated in 1 bottle, plastic | 16729-322-17 | Accord HealthcareIndia | 27 April 2017 |
| 500 tablet, coated in 1 bottle | 67877-447-05 | Ascend LaboratoriesIndia | 24 April 2017 |
| 1000 tablet, coated in 1 bottle | 67877-447-10 | Ascend LaboratoriesIndia | 24 April 2017 |
| 30 tablet, coated in 1 bottle | 67877-447-30 | Ascend LaboratoriesIndia | 24 April 2017 |
| 90 tablet, coated in 1 bottle | 67877-447-90 | Ascend LaboratoriesIndia | 24 April 2017 |
| 100 tablet, film coated in 1 bottle | 65862-743-01 | Aurobindo PharmaIndia | 24 April 2017 |
| 500 tablet, film coated in 1 bottle | 65862-743-05 | Aurobindo PharmaIndia | 24 April 2017 |
| 30 tablet, film coated in 1 bottle | 65862-743-30 | Aurobindo PharmaIndia | 24 April 2017 |
| 10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 65862-743-78 | Aurobindo PharmaIndia | 24 April 2017 |
| 90 tablet, film coated in 1 bottle | 65862-743-90 | Aurobindo PharmaIndia | 24 April 2017 |
| 1000 tablet, film coated in 1 bottle | 65862-743-99 | Aurobindo PharmaIndia | 24 April 2017 |
| 30 tablet, coated in 1 bottle | 71209-081-01 | Cadila PharmaceuticalsIndia | 1 January 2025 |
| 90 tablet, coated in 1 bottle | 71209-081-04 | Cadila PharmaceuticalsIndia | 1 January 2025 |
| 500 tablet, coated in 1 bottle | 71209-081-10 | Cadila PharmaceuticalsIndia | 1 January 2025 |
| 30 tablet, film coated in 1 bottle | 31722-854-30 | Camber PharmaceuticalsIndia | 23 May 2025 |
| 90 tablet, film coated in 1 bottle | 31722-854-90 | Camber PharmaceuticalsIndia | 23 May 2025 |
| 1000 tablet, film coated in 1 bottle | 68462-438-10 | Glenmark PharmaceuticalsIndia | 25 May 2017 |
| 10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 68462-438-11 | Glenmark PharmaceuticalsIndia | 25 May 2017 |
| 30 tablet, film coated in 1 bottle | 68462-438-30 | Glenmark PharmaceuticalsIndia | 25 May 2017 |
| 90 tablet, film coated in 1 bottle | 68462-438-90 | Glenmark PharmaceuticalsIndia | 25 May 2017 |
| 100 tablet, film coated in 1 bottle, plastic | 59746-466-01 | Jubilant Cadista PharmacuticalsIndia | 24 April 2017 |
| 1000 tablet, film coated in 1 bottle, plastic | 59746-466-10 | Jubilant Cadista PharmacuticalsIndia | 24 April 2017 |
| 30 tablet, film coated in 1 bottle, plastic | 59746-466-30 | Jubilant Cadista PharmacuticalsIndia | 24 April 2017 |
| 3 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 59746-466-32 | Jubilant Cadista PharmacuticalsIndia | 24 April 2017 |
| 90 tablet, film coated in 1 bottle, plastic | 59746-466-90 | Jubilant Cadista PharmacuticalsIndia | 24 April 2017 |
| 30 tablet in 1 bottle | 70756-810-30 | Lifestar PharmaIndia | 1 May 2020 |
| 90 tablet in 1 bottle | 70756-810-90 | Lifestar PharmaIndia | 1 May 2020 |
| 30 tablet in 1 bottle | 33342-180-07 | Macleods PharmaceuticalsIndia | 25 April 2017 |
| 90 tablet in 1 bottle | 33342-180-10 | Macleods PharmaceuticalsIndia | 25 April 2017 |
| 10 blister pack in 1 carton / 10 tablet in 1 blister pack | 33342-180-12 | Macleods PharmaceuticalsIndia | 25 April 2017 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 25 April 2002 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Olmesartan 40 mg tablet.
Other strengths and forms of Olmesartan
Clinical summary
Olmesartan is an angiotensin 2 receptor blocker indicated for the treatment of hypertension in adults and children six years of age and older, to lower blood pressure. It is available as tablets for oral use. MedsAcross supplies Olmesartan for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about OlmesartanFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Benicar prescribing information (Cosette Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Olmesartan 40 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.